TamilCOVID-19: Covaxin recommended for 2 to 18-year-olds in India
12 October 2021, 4:43 pm
In a major boost to India’s fight against COVID-19, the Subject Expert Committee (SEC) has given a recommendation to the Drugs Controller General of India (DCGI) for the use of Bharat Biotech’s Covaxin for 2 to 18-year-olds, ANI reported on Tuesday (October 12, 2021). Covaxin, notably, will now become the country’s first COVID-19 vaccine that can be administered to children However, official comment on the same is awaited.
The development comes almost a week after sources claimed that Bharat Biotech, which completed the Phase 2/3 trials of Covaxin for use in children under 18 years of age, has submitted the data to the Central Drugs Standard Control Organisation (CDSCO) for its verification and subsequent approval for Emergency Use Authorisation for the jab.
“Covaxin clinical trial data of 2-18 years age group has been submitted to CDSCO… This is feasible due to the safety of the manufacturing platform and empirical evidence from Phase 1,2 and 3 clinical trials in adults,” sources said.
0
0